-
VALENSA INTERNATIONAL
Our Mission
Enhance health through pure, sustainable and science-based nutraceuticals.
-
-
-
-
Valensa International is a leading innovator of pure, science-based, and clinically effective nutraceutical solutions proven to benefit health and wellness.
Valensa International is a leading innovator of pure, science-based, and clinically effective nutraceutical solutions proven to benefit health and wellness.
For twenty years Valensa has partnered with nutraceutical, food and pharmaceutical companies to bring condition-specific solutions for human and companion-animal well-being to market.
Our commitment to safety, quality and the environment is represented by the United States Pharmacopeia (USP) Dietary Ingredient Verification Program, FDA Good Manufacturing Practice compliance, and sustainability practices.
Valensa is headquartered near Orlando, Florida.
FEATURED PRODUCT
Delivering a standardized lipidosterolic extract of saw palmetto for clinical effectiveness.
SEE WHAT'S NEW WITH USPLUS®FEATURED PRODUCT
Joint health is a broad term, meaning different things to different people. However, one thing is certain; a majority of people are concerned about their joint health as they age. Joint discomfort is not limited to the older demographic. Modern lifestyles challenge joint comfort for all ages with various exercise regimes, sports participation and the common aches and pains we all deal with to varying degrees.
LEARN MORELatest News & Events
Valensa’s Chief Science Officer Presents New Research on Efficacy of a Lipidosterolic Extract of Saw Palmetto
In collaboration with Valensa, leading prostate expert Dr. Stephen Strum has published the most comprehensive, global review of clinical studies to evaluate the consumer benefit of a lipidosterolic extract of Serenoa repens (LSESr), commonly known as saw palmetto. Through an assessment of 40 years of data Strum’s findings validate the effectiveness of an LSESr like Valensa’s USPlus® […]
Valensa CEO Discusses Astaxanthin Market Dynamics in Recent Article
In an interview at the SupplySide West trade show in Las Vegas, Valensa CEO Umasudan (Uma) Pal., noted that while the astaxanthin market has experienced growth over the last decade, “even golden-egg-laying geese can inadvertently be slaughtered.” To learn more about this antioxidant powerhouse, quality and consumer benefits read the entire article.
Have a Question?
Contact us to learn more.
Interested in hearing more of what Valensa has to offer? Please fill out the form below and we will reach out to you with more information, thanks for getting in touch.